USE OF NK-1 RECEPTOR ANTAGONISTS TO MODIFY UNWANTED BEHAVIOR IN DOGS, CATS AND HORSES

Details for Australian Patent Application No. 2002317436 (hide)

Owner PFIZER PRODUCTS INC.

Inventors KILROY, Carolyn, Rose; BRONK, Brian, Scott; HICKMAN, Mary, Anne

Pub. Number AU-A-2002317436

PCT Number PCT/IB02/02847

PCT Pub. Number WO2003/009848

Priority 60/306,692 20.07.01 US

Filing date 15 July 2002

Wipo publication date 17 February 2003

International Classifications

A61K 031/46 - 8-Azabicyclo [3.2.1] octane

A61K 031/4418 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61P 025/22 Drugs for disorders of the nervous system

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 60/306,692 20.07.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002317436

28 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002317437-THERAPEUTIC USES OF LNAMODIFIED OLIGONUCLEOTIDES IN INFECTIOUS DISEASES

2002317435-METHOD, TERMINAL AND SERVER TO PROVIDE AN ESTIMATE OF THE WAITING TIME UP TO THE END OF A PROCESS